Medtronic InSync ICD Gains Panel Support In Tiebreaking 6-5 Vote
This article was originally published in The Gray Sheet
Executive Summary
The recommended post-market requirement for Medtronic's InSync ICD and its pacing counterpart suggests that companies that conduct pivotal studies with a small number of patients will be expected to follow up with a large trial